Key to prostate cancer resistance

A combination of two types of therapy may be more effective in treating castration-resistant prostate cancer.

Vanderbilt researchers isolate Ebola-fighting human antibodies for possible treatment

Vanderbilt University researchers have isolated Ebola-fighting human antibodies – the first of their kind – that could lead to a new treatment for the deadly virus.

Improving breast cancer chemo by testing tumors in a dish

A team of biomedical engineers has developed a new “tumor-in-a-dish” technology that promises to improve the effectiveness of chemotherapy.

Peptide quells “genomic storm”

A cell-penetrating peptide developed at Vanderbilt blocks the signaling pathways that lead to lethal shock caused by bacterial infection.

Members named to Academic Strategic Plan committees

Two committees tasked with fleshing out key initiatives in Vanderbilt’s Academic Strategic Plan are now staffed and ready to begin work.

Vanderbilt continues Ebola virus preparations